Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: SIM0270|DRUG: Palbociclib|DRUG: everolimus
Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd.